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The majority of global cardiovascular disease (CVD) burden falls on people living in low-
and middle-income countries (LMICs). In order to reduce preventable CVD mortality and
morbidity, LMIC health systems and health care providers need to improve the delivery and
quality of CVD care.
Objectives
As part of the Disease Control Priorities Three (DCP3) Study efforts addressing quality
improvement, we reviewed and summarized currently available evidence on interventions
to improve quality of clinic-based CVD prevention and management in LMICs.
Methods
We conducted a narrative review of published comparative clinical trials that evaluated effi-
cacy or effectiveness of clinic-based CVD prevention and management quality improve-
ment interventions in LMICs. Conditions selected a priori included hypertension, diabetes,
hyperlipidemia, coronary artery disease, stroke, rheumatic heart disease, and congestive
heart failure. MEDLINE and EMBASE electronic databases were systematically searched.
Studies were categorized as occurring at the system or patient/provider level and as treating
the acute or chronic phase of CVD.
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Results
From 847 articles identified in the electronic search, 49 met full inclusion criteria and were
selected for review. Selected studies were performed in 19 different LMICs. There were 10
studies of system level quality improvement interventions, 38 studies of patient/provider
interventions, and one study that fit both criteria. At the patient/provider level, regardless of
the specific intervention, intensified, team-based care generally led to improved medication
adherence and hypertension control. At the system level, studies provided evidence that
introduction of universal health insurance coverage improved hypertension and diabetes
control. Studies of system and patient/provider level acute coronary syndrome quality
improvement interventions yielded inconclusive results. The duration of most studies was
less than 12 months.
Conclusions
The results of this review suggest that CVD care quality improvement can be successfully
implemented in LMICs. Most studies focused on chronic CVD conditions; more acute CVD
care quality improvement studies are needed. Longer term interventions and follow-up will
be needed in order to assess the sustainability of quality improvement efforts in LMICs.
Introduction
Cardiovascular disease (CVD) is the leading cause of death globally. While the number of
CVD deaths has not changed significantly in high-income countries since 1990, the number of
deaths has increased by about 66% in low- and middle-income countries (LMICs) over the
same interval[1]. While attempting to address the burden of CVD, LMICs face the challenges
of limited health care budgets and infrastructure as well as constrained professional health
workforce capacity.
In the context of scarce resources available to support health care in LMICs, the imperative
of clinical quality improvement is to get the most out of known effective interventions within the
limitations of available resources rather than recommending unproven interventions that
would require early phase studies or those that would require substantial financial and human
resource investment for implementation. Clinical quality improvement can be implemented
within any setting immediately, and need not be expensive.
Quality care delivery in lower resource settings does not necessarily mean dissemination
and implementation of a universal set of standards formulated in high-income countries. Stan-
dards and interventions should be dictated by context and community capacity. Adaptation to
local settings is necessary to achieve optimal clinical outcomes and patient satisfaction.
As part of the Disease Control Priorities Three (DCP3) Study efforts addressing quality
improvement, we reviewed and narratively summarized currently available evidence on quality
improvement for CVD prevention and management in LMICs. In keeping with the Institute of
Medicine definition of clinical care quality, we focused on studies that compared specific clini-
cal care quality improvement interventions with usual care and specified measurable health
outcomes[2].
Materials and Methods
A conceptual framework guided the systematic review. We specified four domains, cross-cut-
ting between two distinct phases of CVD (acute versus chronic) and two levels of intervention
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(health system versus patient/provider) (Fig 1). Acute phases of CVD, such as acute myocardial
infarction, stroke, and limb ischemia, occur unpredictably. Good outcomes demand timely
clinical responses, which require adequate and accessible facilities, functional transportation
networks, providers prepared to treat cases that present at all hours, and patient awareness of
when and how to seek medical attention. In contrast, chronic phases of CVD, such as diabetes
mellitus, hypertension, and congestive heart failure (CHF), require screening for pre-clinical
risk factors, systematic monitoring for complications, and substantial patient self-care and
engagement in order to initiate and maintain treatment adherence. Good quality chronic phase
care may prevent or delay onset of acute phase manifestations, thereby preventing or delaying
disability or death. We also examined interventions at the health care system and patient/pro-
vider levels. Our team populated the four domains of this two-by-two framework a priori with
potential quality improvement levers, based on our prior knowledge of the field and examples
gleaned from other studies, including other DCP3 reviews.
Fig 1. Quality conceptual framework for cardiovascular diseases, the DCP3.
doi:10.1371/journal.pone.0157036.g001
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Information Sources and Search Strategy
Two authors (EL and AEM) designed an electronic search of MEDLINE and EMBASE elec-
tronic databases for the purpose of capturing published reports of CVD care quality improve-
ment studies carried out in LMICs and published in English between January 2000 and June
2014. Pertinent conditions selected for the search were myocardial infarction, acute coronary
syndrome (ACS), hypertension, cardiovascular disease, diabetes, stroke, cerebrovascular dis-
ease, obesity, CHF, and rheumatic heart disease (RHD). Based on key words identified in an
informal review of publications already known to the authors and a survey of the other DCP3
chapter authors, a second set of search terms related to quality improvement was identified (S1
and S2 Tables). Study designs were limited to controlled clinical trials, comparison studies, sys-
tematic reviews, and meta-analyses. Studies were limited to those published in peer-reviewed
journals or in reports from institutes with rigorous internal reviews. The electronic search was
refined and structured by a research librarian. Search results were considered valid if all of five
key papers identified a priori by coauthors’ review were retrieved by the electronic search[3–7].
The review adhered to PRISMA recommendations for the conduct and reporting of systematic
reviews (S1 Fig).
Eligibility Criteria and Study Selection
Two authors (EL and AEM) independently assessed identified studies for eligibility based on
the title and abstract. Selected full text papers were then independently reviewed by both
authors. Eligibility criteria included: 1) LMIC setting; 2) patient/provider or system level inter-
vention aimed at improving CVD quality of care; 3) outcome included risk factor or disease
screening, case-finding, clinic-based CVD prevention (medication adherence, clinic visits, vital
signs, laboratory results, mortality), behavioral changes (diet or exercise), improved access to
medical care, or clinical guideline implementation; and 4) study design involved a comparison
between a clinical quality improvement intervention and usual care, regardless of whether the
intervention group served as its own control (“before and after” study) or a separate control
group was used.
Data Collection/Data Items/Summary Measures
Data were abstracted and each study was categorized into one or more quadrants of the chapter
rubric (Fig 1). The following information was extracted from each study: study characteristics
(setting, targeted disease, study design, participant number and baseline characteristics), type
of intervention, observation interval, and outcome measures. The main summary measures
were differences in means, proportions of the outcome, and outcome risk reduction. Three
study types were observed most frequently and were therefore identified for potential pooling
in a quantitative analysis: task-shifting in hypertension control, mobile health in diabetes man-
agement, and ACS clinical pathway interventions. Four out of eight task-shifting hypertension
control studies did not report variance around the most common main effect estimate—sys-
tolic blood pressure (SBP) change [8–15]. Only three out of six studies analyzing mobile health
in diabetes management reported variance around mean hemoglobin A1c (HbA1c) change
[16–21]. Too few studies reported on changes in fasting plasma glucose or percent adherence
to medications. ACS clinical pathways studies did not consistently report on the same quality
improvement metrics [3, 5, 22]. Because of heterogeneity of outcomes and lack of reporting on
measures of dispersion about main effect estimates (variance), the authors were unable to per-
form a quantitative analysis.
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Results
Study Selection and Characteristics
The search yielded 847 unique references and all five key papers identified a priori were captured.
Based on a review of titles and abstracts, 273 potentially eligible papers were identified. Of these,
two authors (EL and AEM) concurred that 49 papers reported population-based studies with
clinically meaningful outcomes. The papers were selected for the detailed review (Fig 2). Table 1
presents a summary of study characteristics. All 49 studies are reported in Tables 2–5.
System level-acute phase CVD
Three studies examined interventions in the system level-acute phase category[22–24]
(Table 2). Alexander et al. reported on a project being launched in a rural region within Tamil
Nadu state, India that plans to implement a “hub-and-spoke”model using existing health care
facility and ambulance transportation resources to improve the acute ST-elevation myocardial
infarction care delivery system. Another multi-component intervention study, the Kerala ACS
program included community-based health education programs that promoted self-detection
of acute coronary disease symptoms, rapid self-referral for treatment, and timely self-adminis-
tration of aspirin [22]. The investigators concluded that improved patient awareness of ACS
symptoms and treatments contributed to reduced time-to-thrombolysis achieved by the multi-
component intervention. We found no studies assessing the impact of improved geographical
and temporal coverage of acute care services, including the impact of building more hospitals
Fig 2. Flow diagram describing the systematic literature review process.
doi:10.1371/journal.pone.0157036.g002
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within under-served areas, expanding service hours to include more overnight capacity, or
making revascularization more widely available within the health system.
System level-chronic phase CVD
Most studies in the system level-chronic phase category studied expansion of health insur-
ance coverage [25–32] (Table 3). Two studies evaluated the health impact of Seguro Popular
insurance rolled out in 2002 as part of Mexico’s national universal health insurance plan.
Seguro Popular covered approximately 50 million low-income people who previously had no
formal health insurance–often because working family members participated in the informal
economy [25]. Based on data gathered in Mexican national health and nutrition surveys dur-
ing step-wise introduction of insurance, Bleich et al. found that compared with matched
hypertensive adults without insurance, hypertensive Seguro Popular enrollees had 1.5-fold
higher odds of receiving hypertension treatment and 1.4-fold higher odds of having con-
trolled blood pressure (BP) [25]. A similar study of low-income diabetic patients found those
with Seguro Popular insurance were more likely to receive regular blood glucose control
monitoring and maintain adequate glucose control compared to their matched, uninsured
counterparts [26].











Africa 0 4 0 7* 11*
Asia 2** 1 3** 13* 18*
Eastern Europe 0 0 1 1 2
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3** 0 4** 1 7a
Congestive heart
failure
0 0 0 4 4b
Diabetes 0 2 0 12 14c
Hypertension 0 3 0 17 20d
Rheumatic heart
disease
0 2 0 0 2e
General CVD 0 1 0 0 1f
Stroke 0 0 1 0 1g
TOTAL 3 8 5 34 49
*Mendis et al. counted twice since study conducted in Africa (Nigeria) and Asia (China)
**Prabhakaran et al. counted for both system level and patient/provider level interventions
a-Asia (4), Latin America (2), Europe (1)
b-Latin America (3), Europe (1)
c-Asia (5), Middle East (4), Latin America (3), Asia (2)
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In rural Nigeria, hypertensive patients living in a district where community-based health
insurance was available had significantly lower SBP and diastolic blood pressure (DBP) not
observed in the control group without insurance [27]. In rural China, hypertensive patients
receiving subsidies to defer medication costs had a 9% absolute increase in medication adher-
ence and significantly lower annual out-of-pocket medical costs [28].
Patient/provider level-acute phase CVD
Most studies in the patient/provider level–acute phase category studied ACS clinical pathways
[3, 5, 22, 33] (Table 4). Berwanger et al. randomized large urban hospitals in Brazil to either a
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doi:10.1371/journal.pone.0157036.t002
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multifaceted quality improvement program with educational materials, reminders, treatment
algorithms and training visits or to usual care. The intervention group had 2.64 higher odds
(95% confidence interval 1.28 to 5.45) of receiving evidence-based ACS treatment within the
first 24 hours following symptom onset[5]. However, there was no difference observed in
30-day mortality or rate of in-hospital repeat cardiovascular events.
In urban China, Du et al. randomized hospitals to implementation of a United States guide-
line-based ACS pathway, along with interval clinical performance audits and feedback
throughout the intervention period and compared the results of these interventions to hospitals
continuing usual care practices. Intervention hospitals had higher rates of discharge on recom-
mended therapies compared to usual care hospitals, but no difference was observed in other
indicators, including reperfusion within 12 hours of symptom onset in ST-elevation myocar-
dial infarction cases, door-to-needle time, door-to-balloon time, or proportion of high-risk
patients undergoing angiography[3]. Similar to the Berwanger et al. study, there was no signifi-
cant difference in mortality or cardiovascular morbidity events. In a third study, Prabhakaran
et al. enrolled 34 hospitals in the Kerala region of India to serve as their own controls in a pre-
and post-intervention comparison design. After the multi-faceted quality improvement inter-
vention, there was a significant median reduction of 54 minutes in time-to-thrombolysis from
193.0 to 139.0 minutes and a significant increase in utilization of evidence-based medications
[22].
Patient/provider level-chronic phase CVD
The majority of selected studies (33/49) were in the patient/provider level-chronic phase cate-
gory [8–21, 35–54] (Table 5). CVD patients are often prescribed several medications for pri-
mary or secondary prevention, makingmedication adherence a key challenge to delivering
quality CVD clinical care worldwide. Thus most interventions were related to chronic medica-
tion adherence. Types of medication adherence interventions included use of fixed-dose com-
bination pills, “mobile” health care, task shifting, clinical guideline implementation, and
patient education.
Improving patients’ medication adherence through combination pills. Thom et al. ran-
domized high-risk CVD patients in India (one of four countries studied) to receive combina-
tion pills or the usual, multiple-pill therapy. After a mean follow-up of about 15 months,
Indian participants randomized to combination pills had a 25% higher absolute adherence
compared to those randomized to usual care (89.1% vs 63.6%, unadjusted relative risk 1.4, 95%
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and low-density lipoprotein (LDL) compared with participants randomized to multiple-pill
treatments [8]. In another study, Yusuf et al. also found small but significant improvement in
adherence among high CVD risk Indian subjects randomized to a combination pill containing
multiple BP medications, statins, and aspirin [9]. A follow-up study showed that high-dose
combination pills improved BP and lipid control in high CVD risk Indian subjects compared
to low-dose combination pills, while both formulations had similar rates of tolerability [35].
Zou et al. found that high CVD risk rural Chinese participants achieved an 11% higher absolute
adherence rate after they were offered combination pills in a pre- and post-intervention com-
parison design (84% vs 73%, p = 0.000)[10]
Improving patients’ medication adherence through mobile health interventions.
Twelve studies investigated the role of mobile health in prevention and management of CHF,
diabetes, hypertension, and coronary artery disease in LMICs [16–21, 36–39, 41]. Chronic
CHF patients in Argentina were randomized to a telemedicine intervention in which nurses
called patients to adjust medications depending on their symptoms and provided counseling
and education or to usual care. Patients in the intervention arm had a 20% relative risk reduc-
tion (RR = 0.80, 95% confidence interval 0.66 to 0.97, p = 0.026) in the primary composite out-
come of all-cause mortality and CHF hospitalizations, driven mostly by the latter outcome
component[36]. A follow-up study showed that even after three years, CHF hospitalizations,
medication adherence rates, and quality of life scores had improved significantly more in the
intervention group [37]. Similarly, Nesari et al. showed that Iranian diabetic patients random-
ized to a nurse telephone follow-up intervention had significant improvements in their HbA1c
and adherence to healthy lifestyle changes compared to those randomized to usual care [16].
Four studies evaluated the effects of automated phone texts on diabetes and coronary artery
disease prevention. Ramachandran et al. and Shetty et al. found that automated SMS (short
message service) messages led to improved glycemic control in Indians with pre-diabetes and
diabetes[17, 18]. Goodarzi et al. showed an absolute decrease in HbA1c in Iranian diabetic sub-
jects who received automated SMS messages[19]. Khonsari et al. revealed that automated SMS
messages led to higher medication adherence rates in Malaysian patients after hospital dis-
charge following ACS [38]. It is important to note that all four studies only included partici-
pants with regular access to mobile phones with text receiving capabilities.
Task shifting to increase patients’ medication adherence. Task shifting refers to the
redistribution of tasks among health workforce teams, often from a few, highly trained health
providers to a larger contingent of providers with less formal health care training[55]. Our
review identified six studies evaluating task shifting for improving patient adherence to pre-
scribed medications [11–15, 42]. Some studies coupled task shifting with increased access to
affordable or free medications [12, 13] or family-based home health education and supplemen-
tal training of general practitioners [15].
Five task-shifting studies targeted hypertensive patients[11–15]. Regardless of the approach,
intensified, team-based care led to improved hypertension control. Kengne et al. carried out a
large trial of hypertensive participants enrolled in a nurse-led clinic in Cameroon. Erhun et al.
evaluated the role of pharmacist-led clinics in Nigerian patients with hypertension. Adeyemo
et al. randomized Nigerian participants with hypertension to clinic-based care with home visits
or to clinic-based care only. Jafar et al. was a cluster-randomized, controlled trial of two differ-
ent interventions, home health education by health aides and training of general practitioners,
in a population of Pakistani patients with hypertension.
Two studies focused on task shifting interventions in diabetic patients [16, 42]. Nesari et al.,
as mentioned above, showed that having nurses call patients regularly to reinforce lifestyle
changes and adjust medication doses led to a significant decrease in HbA1c. The intervention
group also showed increased rates of adherence to lifestyle changes and glucose monitoring.
Quality Improvement for CVD Care in Low- and Middle-Income Countries: A Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0157036 June 14, 2016 17 / 28
Guideline implementation and provider education leading to improved patient out-
comes. Health care provider education and guideline implementation have the potential to
standardize, improve, and sustain quality of care for vascular and other conditions in LMICs.
Studies of the impact of physician education and guideline dissemination yielded mixed results
[43–47]. Qureshi et al. showed that physician education through workshops and guideline dis-
semination led to significant improvements in quality of hypertension management. Anchala
et al. revealed that providing physicians with a clinical decision support system to undertake
guideline-based hypertension management led to significant reductions in SBP. Mendis et al.
showed that dissemination of an evidence-based cardiovascular risk management package led
to significant reductions in SBP in both Chinese and Nigerian primary care clinics compared
to usual care (China: 13.3 vs 9.4mm Hg, p<0.0001; Nigeria: 11.0 vs 6.6mm Hg, p = 0.0002)
[45]. However, Reutens et al. and Steyn et al. showed conflicting results and highlighted the
fact that guideline dissemination alone did not lead to implementation or improve health out-
comes in South African clinics.
Educating patients to enhance health outcomes. The review found eight studies that
evaluated disease management education among patients with hypertension, diabetes, and
CHF. [48–54]. Alhalaiqa et al. and Mohammadi et al. showed that hypertensive patients in Jor-
dan and Iran, respectively, who were randomized to medication adherence education and
motivational group meetings had improved SBP and medication adherence compared to those
participants in the control groups. Likewise, Tan et al. revealed that Malaysian patients with
poorly controlled diabetes who were randomized to monthly diabetes education programs
resulted in 0.9% absolute reduction in HbA1c (8.75 vs 9.67%, p<0.001), changes not observed
in the control group [51]. Bocchi et al. reported Brazilian CHF patients randomized to disease
management programs had a delay in median follow-up time to first hospitalization by 2.2
years (4.21 vs 2.06 years, p = 0.0041) compared to those in the control group, though mortality
was similar in both groups [54]. Conversely, Andryukhin et al. did not find that disease man-
agement led to decreased hospital admissions or mortality, but did lead to improved functional
status and quality of life.
Discussion
Our systematic review identified 49 original studies of CVD care quality improvement in
LMICs. Taken together, the evidence suggests that quality improvement programs have the
potential to improve CVD care in LMICs, whether for treating acute events or in long-term
prevention and chronic disease management. Not all approaches reviewed were consistently
effective, and we did not find evidence supporting all the approaches we intended to assess a
priori (Figs 3 and 4).
System level-acute phase CVD
Our systematic review found limited evidence in the acute phase-system level category. Per-
haps poor underlying infrastructure in low resource settings presents daunting challenges to
re-organize complex health delivery systems [56]. Just as likely, governments, non-governmen-
tal, and private sector organizations often introduce system improvements without rigorous
systematic study. Therefore, health effects of system level changes may go unmeasured or unre-
ported. Conducting randomized comparison studies in low- and middle-income settings may
be limited by lack of research capacity, perception of causing unwanted delay in care delivery,
“contamination” between intervention and control sites, and ethical concerns. The lack of evi-
dence is unfortunate because timely intervention can dramatically improve acute CVD out-
comes, and delays may result in unnecessary death or disability. Awareness, acceptability,
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affordability, and availability are all common barriers that can delay treatment of acute events.
Community education and system-wide infrastructure, logistics, and human resource planning
can overcome barriers to timely and appropriate care for acute CVD. Integration of private sec-
tor ambulance companies, hospitals, and providers is an important part of achieving improved
quality of acute CVD care in LMICs, where the private sector provides a large proportion of
health care and may be in the position to efficiently fill gaps in public health care systems [57].
System level-chronic phase CVD
Unfortunately, many CVD patients in LMICs remain untreated or incompletely treated with
standard oral medications for secondary prevention [58]. Our review suggests that system level
quality improvement efforts can lead to measurable improvements in health status in LMIC
Fig 3. Examples of acute phase CVD quality improvement interventions identified in the DCP3 systematic review. Types of interventions targeting
three levels of acute phase CVD prevention and management. Bullets in bold type are supported by evidence from the review. Bullets without bold type
indicate that no supporting evidence was found in the review and are potential areas for further research.
doi:10.1371/journal.pone.0157036.g003
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patients with chronic CVDs. Implementation of universal health insurance led to significant
improvements in chronic disease management in Latin America, Africa, and Asia [25–28].
Our review captured no studies of the impact of “essential medicines” designations and price
controls or pharmaceutical market regulation on the quality of CVD clinical care.
In sub-Saharan Africa, the substantial infrastructure investment that turned the tide of the
HIV epidemic is now being leveraged for chronic non-communicable disease management
[59]. Groups like the Kenya-based Academic Model Providing Access to Healthcare
(AMPATH) have leveraged this health system platform to build a comprehensive, multi-level
approach to quality improvement in order to improve cardiovascular care in the communities
they serve[60, 61]. Results of this multi-level intervention are expected soon.
Fig 4. Examples of chronic phase CVD quality improvement interventions identified in the DCP3 systematic review. Types of interventions targeting
three levels of chronic phase CVD prevention and management. Bullets in bold are supported by evidence from the review. Bullet without bold type indicate
that no supporting evidence was found in the review and are potential areas for further research.
doi:10.1371/journal.pone.0157036.g004
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System level interventions have been systematically evaluated through pre- and post-inter-
vention “natural experiment” comparisons, observational comparisons of intervention partici-
pants and matched usual care participants, or comparisons of geographic areas randomly
assigned to receive or not receive the intervention. Stepped-wedge trials introduce interven-
tions to couple step-wise active and systematic program implementation with evaluation [62].
As in the Mexican Seguro Popular studies, repeated population-based surveys (national census
or health surveys) can be leveraged to measure changes in chronic CVD risk factors and out-
comes. Quality improvement studies will be most feasible where key outcomes are part of, or
added to, ongoing surveys.
Patient/provider–acute phase CVD
Adopting clinical practice guidelines from high-income countries to LMICs appears to be a
great opportunity both for implementing quality improvement standards and benchmarking
significant practice and outcome improvements. The ACS and stroke quality improvement
studies identified in our review showed some clinical process measure improvements, but like
high-income region studies, quality did not consistently improve for all pre-specified outcomes
[3, 5, 34]. Success of acute phase CVD clinical pathway interventions likely depends on the sup-
port of health care providers and administrators, and tailoring to the specific context of the
participating health care system (i.e., availability of treatments and financial protection for
patients) [63]. Lessons learned from these programs may be helpful for the design of future
acute, patient/provider level CVD quality improvement studies. Despite their limitations, these
ambitious studies demonstrated that large-scale and complex quality improvement programs
can be implemented in LMIC hospitals. Absent from our review were studies measuring the
impact of physician education on diagnostic accuracy or clinical decision-making related to
acute cardiovascular disorders.
Patient/provider–chronic phase CVD
Adherence to life saving medications and lifestyle changes is suboptimal world-wide, regardless
of country income level [58]. The most consistent general finding among selected LMIC studies
was that increased intensity of care improved chronic disease and risk factor outcomes, regard-
less of how or through whom it was delivered. While care intensification inevitably requires
up-front investment, this investment may be offset by improved downstream CVD outcomes,
health gains, and cost-savings. A modeling study by Gaziano et al. projected that despite added
costs of hiring community health workers to manage hypertension in South Africa, the inter-
vention would be cost-effective due to health gains and cost savings from prevented hospital
admissions and chronic disease complications [64]. The trials reviewed also suggest that com-
bination pills have the potential to improve medication adherence and improve risk factor con-
trol in high-risk patients without necessarily adding extra costs. Efforts to efficiently
manufacture and gain regulatory approval for combination medications are underway [65].
Rapidly increasing access to mobile telecommunications technology may also be a promis-
ing tool for chronic disease management. There are now almost seven billion mobile phone
users world-wide with more than three-quarters of these users living in LMICs [66]. A 2012
Cochrane review cautiously concluded that there was some limited evidence that mobile phone
messaging may be beneficial in self-management of chronic diseases [67]. This was based on
evidence from four studies, all performed within high-income countries. We found a number
of studies in LMICs that successfully leveraged the ubiquity and low cost of mobile technology
to improve CHF, hypertension, and diabetes care outcomes.
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We found that efforts to improve quality care through physician education and guideline
dissemination yielded inconsistent results [43, 44, 46, 47]. Guideline dissemination did not
Fig 5. Duration of chronic cardiovascular disease or risk factor management studies identified in the DCP3
systematic review.
doi:10.1371/journal.pone.0157036.g005
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lead to actual implementation in all cases. Gaining buy-in from providers appears to be impor-
tant for success. Allocating time for education and feedback and strategically inserting guide-
line information into the flow of clinical practice may increase the chance that guidelines are
actually implemented.
Limitations
Our review and the studies we reviewed had limitations, so our results should be interpreted
with caution. Due to the diversity of interventions and conditions, we were unable to summa-
rize effect sizes in a meta-analysis. It is possible that most of our included studies were pub-
lished because of “positive” results—due to the heterogeneity in interventions and targets, we
were not able to formally evaluate the results of our review for evidence of publication bias.
Also important is that most study durations were relatively short term (<12 months) and sus-
taining intervention effects may be a big challenge when these programs are implemented in
real clinical settings (Fig 5). As in high-income countries, most investigators studied clinical
process measures, and did not report on hard clinical outcomes, which may be more vulnerable
to “gaming” the system to produce only nominal improvements and other unintended conse-
quences when these interventions are introduced into routine practice.
Conclusions
We identified good evidence that short-term quality improvement interventions improved the
quality of cardiovascular care in low- and middle-income countries, especially for chronic con-
ditions delivered at the patient/provider level. Most studies were short-term. At the patient/
provider level, intensified, team-based care generally led to improved medication adherence
and hypertension control. At the system level, studies provided evidence that introduction of
universal health insurance coverage improved hypertension and diabetes control. Studies of
system and patient/provider level ACS quality improvement interventions yielded inconclusive
results.
What is needed now is more evidence that quality improvement can be sustained in the
long term while remaining effective and affordable. Collecting data elements common to
implementation research such as acceptability, sustainability, local context, and affordability
and collecting and assessing qualitative and process data will help ensure that both positive and
negative studies will guide implementation and future research[68].
The majority of CVD patients now live in LMICs, and demographic trends virtually guaran-
tee that the number and proportion will grow in coming decades. In order to ensure that each
of these patients receives high quality preventive and acute care, we will need to draw on prom-
ising research on clinical quality improvement in order to make the most of the resources
directly at hand.
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